Mainstream

Avadel raises 2025 revenue guidance to $275M as LUMRYZ patient base grows 63% year-over-year

Avadel raises 2025 revenue guidance to $275M as LUMRYZ patient base grows 63% year-over-year

Post ContentavdlRead More

You might also be interested in reading Do Kwon dismisses allegation of cashing out $2.7B from Terra (LUNA), UST.

August 8, 2025
In Mainstream